CRBP
Price:
$8.26
Market Cap:
$103.54M
Corbus Pharmaceuticals Holdings, Inc. operates as a biopharmaceutical firm, concentrating on creating immune modulators designed to combat immuno-oncology and various fibrotic conditions. Its pipeline includes lenabasum, an orally administered small molecule. This compound selectively activates cannabinoid receptor type 2 (CB2) and is currently undergoing Phase II clinical trials for the treatment of systemic lupus erythematosus. The company is also advancing CRB-601, an anti-integrin monoclonal antibody (mAb) engineered to inhibit the activation of transforming growth factor ß (TGFß), which it is developing for both cancer and fibrotic indications. Another key asset is CRB-602, an anti-avß6...[Read more]
Industry
Biotechnology
IPO Date
2014-10-27
Stock Exchange
NASDAQ
Ticker
CRBP
According to Corbus Pharmaceuticals Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -70.89%. This represents a change of 286.51% compared to the average of -18.34% of the last 4 quarters.
The mean historical ROE of Corbus Pharmaceuticals Holdings, Inc. over the last ten years is -155.94%. The current -70.89% ROE has changed -54.54% with respect to the historical average. Over the past ten years (40 quarters), CRBP's ROE was at its highest in in the December 2023 quarter at 116.17%. The ROE was at its lowest in in the September 2023 quarter at -3232.31%.
Average
-155.94%
Median
-117.58%
Minimum
-1160.42%
Maximum
645.97%
Discovering the peaks and valleys of Corbus Pharmaceuticals Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 473.71%
Maximum Annual ROE = 645.97%
Minimum Annual Increase = -481.68%
Minimum Annual ROE = -1160.42%
| Year | ROE | Change |
|---|---|---|
| 2025 | -53.24% | 88.60% |
| 2024 | -28.23% | -104.37% |
| 2023 | 645.97% | -481.68% |
| 2022 | -169.24% | 156.76% |
| 2021 | -65.92% | -73.18% |
| 2020 | -245.76% | -78.82% |
| 2019 | -1160.42% | 473.71% |
| 2018 | -202.27% | 260.49% |
| 2017 | -56.11% | -74.98% |
| 2016 | -224.22% | 127.62% |
The current ROE of Corbus Pharmaceuticals Holdings, Inc. (CRBP) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
188.16%
5-year avg
65.87%
10-year avg
-155.94%
Corbus Pharmaceuticals Holdings, Inc.’s ROE is greater than Applied Therapeutics, Inc. (-65.63%), greater than Elicio Therapeutics, Inc. (-2748.16%), greater than Molecular Partners AG (-66.19%), greater than Cardiff Oncology, Inc. (-95.50%), greater than Rani Therapeutics Holdings, Inc. (-245.45%), greater than Milestone Pharmaceuticals Inc. (-339.38%), greater than Forte Biosciences, Inc. (-106.16%), greater than PepGen Inc. (-59.89%), less than Innate Pharma S.A. (593.93%), greater than Alector, Inc. (-295.17%),
| Company | ROE | Market cap |
|---|---|---|
| -65.63% | $14.86M | |
| -2748.16% | $73.48M | |
| -66.19% | $143.29M | |
| -95.50% | $82.73M | |
| -245.45% | $51.11M | |
| -339.38% | $111.66M | |
| -106.16% | $247.86M | |
| -59.89% | $123.81M | |
| 593.93% | $169.96M | |
| -295.17% | $194.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corbus Pharmaceuticals Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Corbus Pharmaceuticals Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Corbus Pharmaceuticals Holdings, Inc.'s ROE?
How is the ROE calculated for Corbus Pharmaceuticals Holdings, Inc. (CRBP)?
What is the highest ROE for Corbus Pharmaceuticals Holdings, Inc. (CRBP)?
What is the 3-year average ROE for Corbus Pharmaceuticals Holdings, Inc. (CRBP)?
What is the 5-year average ROE for Corbus Pharmaceuticals Holdings, Inc. (CRBP)?
How does the current ROE for Corbus Pharmaceuticals Holdings, Inc. (CRBP) compare to its historical average?